Hyaluronidase is the enzyme-based substrate that breaks the hyaluronic acid present in the body, and increase the absorption of fluids or the medicines in the body administered subcutaneously or intramuscularly over the intravenous route. Hyaluronidase power injections are used in various applications like non-invasive tumor imaging in cosmetics treatments, cancer metastasis, numerous applications in cancer therapy, and ophthalmic therapeutic. One particularly attractive feature of hyaluronidase is reversibility dissolution of HA hyaluronic fillers in aesthetic procedures.
As per scientific study, dermal filler treatment based incidence of impending necrosis has been observed at 0.001 percent (1 in 100,000 cases). HA filler injection based vascular compromise should be treated instantly and hyaluronidase power injections is used as an effective treatment option. In addition, HA dermal filler based allergic or immunogenic reaction can be effectively managed by the hyaluronidase power injections.
COVID-19 pandemic had affected the global economy and has decreased the production and demand of hyaluronidase power injections. As per U. S. study, there were 70% decline in the physician’s office visits in the last 6 months in the U. S. This negative trend of declining visits is expected to reduce significant revenue of the hyaluronidase power injections procedure during the COVD-19 pandemic. In addition, disruption in the supply chain and declined procedure adoption rate is expected to evidence short term negative growth of the hyaluronidase power injections market.
A rise in awareness regarding aesthetic look has increased the demand for cosmetics and aesthetics procedures. The increase in demand for the hyaluronidase power injections market across the cosmetologists and dermatologists is projected to boost the demand of hyaluronidase injection in the global market. Increase in per capita income and smart living standard is expected to drive the growth of the global hyaluronidase power injections market. Additionally, increased rate of geriatric patients opting for aesthetic non-surgical procedures, and favorable remunerated policies have also fueled the market globally. However, various adverse effects or the associated complications during medication hampers the hyaluronidase power injections market growth.
Globally the hyaluronidase power injections market is segmented based on source, application, distribution channel, and region.
Based on source, the hyaluronidase power injections market is segmented as:
Based on application, the hyaluronidase power injections market is segmented as:
Based on the distribution channel, hyaluronidase power injections market is segmented as:
Based on regions, hyaluronidase power injections market is segmented as followed:
The animal-derived hyaluronidase power injections market segment is projected to account for the higher revenue share in the market owing to most approved and commercialized brands are derived from animal sources (bovine and porcine). The dermatology segment gains traction because of the growing interest of consumers with various skin diseases and disorders in the hyaluronidase power injections market. However, lack of skilled workforce to perform procedures and high cost is expected to impact negatively on the growth of hyaluronidase power injections market.
North America continues to hold the holds the major global market share due to high adoption of advanced aesthetic procedures and a substantial number of dermatological clinics. European hyaluronidase power injections market is expected to gain significant traction owing to launch of innovative products in the region. Asia Pacific region is anticipated to witness the lucrative opportunity due to increased aesthetic awareness among the population in the hyaluronidase power injections market. In addition, Japan and China are the most advanced market in the East Asia with high dominance of the regional players in the market. Middle East and Africa is a least opportunistic market owing to lower per capita income and awareness.
The key players contributing to the hyaluronidase power injections market are Sun Pharmaceuticals Industries, PrimaPharm, Valeant Pharmaceuticals, Amphastar Pharmaceuticals, Halozyme Therapeutics, CooperSurgical Fertility, Shreya Life Science, Stemcell Technologies, Bausch & Lomb Incorporated, Anika Therapeutics, and others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, source, application, and distribution channel.
The report on hyaluronidase power injections market covers exhaustive analysis on:
Regional analysis for hyaluronidase power injections market includes
Report on hyaluronidase power injections market highlights: